The DOI matches its Crossref record; 59 of the 59 references it cites were found in a registry or an index.
Effectiveness and safety of non-steroidal anti-inflammatory drugs and opioid treatment for knee and hip osteoarthritis: network meta-analysis
Open accessAbstract
Objective: To assess the effectiveness and safety of different preparations and doses of non-steroidal anti-inflammatory drugs (NSAIDs), opioids, and paracetamol for knee and hip osteoarthritis pain and physical function to enable effective and safe use of these drugs at their lowest possible dose. Design: Systematic review and network meta-analysis of randomised trials. Data sources: Cochrane Central Register of Controlled Trials (CENTRAL), Medline, Embase, regulatory agency websites, and ClinicalTrials.gov from inception to 28 June 2021. Eligibility criteria for selecting studies: Randomised trials published in English with ≥100 patients per group that evaluated NSAIDs, opioids, or paracetamol (acetaminophen) to treat osteoarthritis. Outcomes and measures: The prespecified primary outcome was pain. Physical function and safety outcomes were also assessed. Review methods: Two reviewers independently extracted outcomes data and evaluated the risk of bias of included trials. Bayesian random effects models were used for network meta-analysis of all analyses. Effect estimates are comparisons between active treatments and oral placebo. Results: 192 trials comprising 102 829 participants examined 90 different active preparations or doses (68 for NSAIDs, 19 for opioids, and three for paracetamol). Five oral preparations (diclofenac 150 mg/day, etoricoxib 60 and 90 mg/day, and rofecoxib 25 and 50 mg/day) had ≥99% probability of more pronounced treatment effects than the minimal clinically relevant reduction in pain. Topical diclofenac (70-81 and 140-160 mg/day) had ≥92.3% probability, and all opioids had ≤53% probability of more pronounced treatment effects than the minimal clinically relevant reduction in pain. 18.5%, 0%, and 83.3% of the oral NSAIDs, topical NSAIDs, and opioids, respectively, had an increased risk of dropouts due to adverse events. 29.8%, 0%, and 89.5% of oral NSAIDs, topical NSAIDs, and opioids, respectively, had an increased risk of any adverse event. Oxymorphone 80 mg/day had the highest risk of dropouts due to adverse events (51%) and any adverse event (88%). Conclusions: Etoricoxib 60 mg/day and diclofenac 150 mg/day seem to be the most effective oral NSAIDs for pain and function in patients with osteoarthritis. However, these treatments are probably not appropriate for patients with comorbidities or for long term use because of the slight increase in the risk of adverse events. Additionally, an increased risk of dropping out due to adverse events was found for diclofenac 150 mg/day. Topical diclofenac 70-81 mg/day seems to be effective and generally safer because of reduced systemic exposure and lower dose, and should be considered as first line pharmacological treatment for knee osteoarthritis. The clinical benefit of opioid treatment, regardless of preparation or dose, does not outweigh the harm it might cause in patients with osteoarthritis. Systematic review registration: PROSPERO number CRD42020213656
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
da Costa, B. R., Reichenbach, S., Keller, N., Nartey, L., Wandel, S., Jüni, P., & Trelle, S. (2017) · The Lancet · doi:10.1016/s0140-6736(17)31744-0 · Cited by 522
Self-citationRetractedda Costa, B. R., Reichenbach, S., Keller, N., Nartey, L., Wandel, S., Jüni, P., & Trelle, S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)30002-2 · Cited by 418
Self-citationRetractedR: A Language and Environment for Statistical Computing
R Core Team (2025) · doi:10.32614/r.manuals · Cited by 352,181
Statistical power analysis for the behavioral sciences
(1990) · Computers, Environment and Urban Systems · doi:10.1016/0198-9715(90)90050-4 · Cited by 65,269
Statistical Power Analysis for the Behavioral Sciences (2nd ed.).
Lachenbruch, P. A., & Cohen, J. (1989) · Journal of the American Statistical Association · doi:10.2307/2290095 · Cited by 37,395
Vos, T., Lim, S. S., Abbafati, C., Abbas, K. M., Abbasi, M., Abbasifard, M., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abdelalim, A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30925-9 · Cited by 19,358
Vos, T., Allen, C., Arora, M., Barber, R. M., Bhutta, Z. A., Brown, A., Carter, A., Casey, D. C., Charlson, F. J., Chen, A. Z., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(16)31678-6 · Cited by 7,253
Bombardier, C., Laine, L., Reicin, A., Shapiro, D., Burgos-Vargas, R., Davis, B., Day, R., Ferraz, M. B., Hawkey, C. J., Hochberg, M. C., et al. (2000) · New England Journal of Medicine · doi:10.1056/nejm200011233432103 · Cited by 4,027
OARSI guidelines for the non-surgical management of knee, hip, and polyarticular osteoarthritis
Bannuru, R. R., Osani, M. C., Vaysbrot, E. E., Arden, N. K., Bennell, K., Bierma-Zeinstra, S. M. A., Kraus, V. B., Lohmander, L. S., Abbott, J. H., Bhandari, M., et al. (2019) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2019.06.011 · Cited by 3,542
Checking consistency in mixed treatment comparison meta-analysis
Dias, S., Welton, N. J., Caldwell, D. M., & Ades, A. E. (2010) · Statistics in Medicine · doi:10.1002/sim.3767 · Cited by 2,521 · cited 1×
“46 Consistency was assessed by using a stepwise approach.”
MethodCardiovascular Events Associated with Rofecoxib in a Colorectal Adenoma Chemoprevention Trial
Bresalier, R. S., Sandler, R. S., Quan, H., Bolognese, J. A., Oxenius, B., Horgan, K., Lines, C., Riddell, R., Morton, D., Lanas, A., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050493 · Cited by 2,519
Kolasinski, S. L., Neogi, T., Hochberg, M. C., Oatis, C., Guyatt, G., Block, J., Callahan, L., Copenhaver, C., Dodge, C., Felson, D., et al. (2020) · Arthritis Care & Research · doi:10.1002/acr.24131 · Cited by 2,516
Self-citationCombination of direct and indirect evidence in mixed treatment comparisons
Lu, G., & Ades, A. E. (2004) · Statistics in Medicine · doi:10.1002/sim.1875 · Cited by 2,166
Bayesian Approaches to Clinical Trials and Health‐Care Evaluation
Spiegelhalter, D. J., Abrams, K. R., & Myles, J. P. (2003) · Wiley eBooks · doi:10.1002/0470092602 · Cited by 1,673
Vital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
Paulozzi, L. J., Jones, C. M., Mack, K. A., & Rudd, R. A. (2011) · PubMed · Cited by 1,529
Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis
Stettler, C., Wandel, S., Allemann, S., Kastrati, A., Morice, M. C., Schömig, A., Pfisterer, M. E., Stone, G. W., Leon, M. B., de Lezo, J. S., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61444-5 · Cited by 1,428
Self-citationVariance imputation for overviews of clinical trials with continuous response
Follmann, D., Elliott, P., Suh, I., & Cutler, J. (1992) · Journal of Clinical Epidemiology · doi:10.1016/0895-4356(92)90054-q · Cited by 1,385
Cardiovascular safety of non-steroidal anti-inflammatory drugs: network meta-analysis
Trelle, S., Reichenbach, S., Wandel, S., Hildebrand, P., Tschannen, B., Villiger, P. M., Egger, M., & Juni, P. (2011) · BMJ · doi:10.1136/bmj.c7086 · Cited by 1,166
Krebs, E. E., Gravely, A., Nugent, S., Jensen, A. C., DeRonne, B., Goldsmith, E. S., Kroenke, K., Bair, M. J., & Noorbaloochi, S. (2018) · JAMA · doi:10.1001/jama.2018.0899 · Cited by 983
Risk of cardiovascular events and rofecoxib: cumulative meta-analysis
Jüni, P., Nartey, L., Reichenbach, S., Sterchi, R., Dieppe, P. A., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)17514-4 · Cited by 846
Self-citationNuesch, E., Dieppe, P., Reichenbach, S., Williams, S., Iff, S., & Juni, P. (2011) · BMJ · doi:10.1136/bmj.d1165 · Cited by 730
Opioids for Chronic Noncancer Pain: A Systematic Review and Meta-analysis
Busse, J. W., Wang, L., Kamaleldin, M., Craigie, S., Riva, J. J., Montoya, L., Mulla, S. M., Lopes, L. C., Vogel, N., Chen, E., et al. (2018) · JAMA · doi:10.1001/jama.2018.18472 · Cited by 716
Guideline for opioid therapy and chronic noncancer pain
Busse, J. W., Craigie, S., Juurlink, D. N., Buckley, D. N., Wang, L., Couban, R. J., Agoritsas, T., Akl, E. A., Carrasco-Labra, A., Cooper, L., et al. (2017) · Canadian Medical Association Journal · doi:10.1503/cmaj.170363 · Cited by 707
Self-citationVital signs: overdoses of prescription opioid pain relievers---United States, 1999--2008.
(2011) · PubMed · Cited by 640
Wandel, S., Juni, P., Tendal, B., Nuesch, E., Villiger, P. M., Welton, N. J., Reichenbach, S., & Trelle, S. (2010) · BMJ · doi:10.1136/bmj.c4675 · Cited by 578
Altman, R., Brandt, K., Hochberg, M., Moskowitz, R., Bellamy, N., Bloch, D. A., Buckwalter, J., Dougados, M., Ehrlich, G., Lequesne, M., et al. (1996) · Osteoarthritis and Cartilage · doi:10.1016/s1063-4584(05)80101-3 · Cited by 577
Bayesian approaches to random-effects meta-analysis: a comparative study
Smith, T. C., Spiegelhalter, D. J., & Thomas, A. (1995) · Statistics in Medicine · doi:10.1002/sim.4780142408 · Cited by 568 · cited 1×
“33 36 37 These models fully preserve the direct randomised comparison within each trial, but allow the comparison of all available interventions across trials, and account for multiple comparisons in multiarm trials.”
BackgroundSmall study effects in meta-analyses of osteoarthritis trials: meta-epidemiological study
Nuesch, E., Trelle, S., Reichenbach, S., Rutjes, A. W. S., Tschannen, B., Altman, D. G., Egger, M., & Juni, P. (2010) · BMJ · doi:10.1136/bmj.c3515 · Cited by 559 · cited 2×
“29 Web-appendix 12 shows that trials included in our analyses generally had a lower risk of bias, which is reassuring.”
BackgroundMethodDias, S., Welton, N. J., Sutton, A. J., & Ades, A. E. (2011) · Bristol Research (University of Bristol) · Cited by 553
Self-citationInternational Narcotics Control Board
United Nations Office on Drugs and Crime (2021) · Narcotic Drugs · doi:10.18356/9789210056373c026 · Cited by 454
The Comparative Safety of Analgesics in Older Adults With Arthritis
Solomon, D. H. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.391 · Cited by 416
Oral or transdermal opioids for osteoarthritis of the knee or hip
da Costa, B. R., Nüesch, E., Kasteler, R., Husni, E., Welch, V., Rutjes, A. W., & Jüni, P. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003115.pub4 · Cited by 347
Self-citationMeta-analysis: Chondroitin for Osteoarthritis of the Knee or Hip
Reichenbach, S., Sterchi, R., Scherer, M., Trelle, S., Bürgi, E., Bürgi, U., Dieppe, P. A., & Jüni, P. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-146-8-200704170-00009 · Cited by 316
Self-citationBjordal, J. M., Klovning, A., Ljunggren, A. E., & Slørdal, L. (2007) · European Journal of Pain · doi:10.1016/j.ejpain.2006.02.013 · Cited by 296
Hawker, G. A., Croxford, R., Bierman, A. S., Harvey, P. J., Ravi, B., Stanaitis, I., & Lipscombe, L. L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091286 · Cited by 260
Self-citationSmith, S. R., Deshpande, B. R., Collins, J. E., Katz, J. N., & Losina, E. (2016) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2016.01.135 · Cited by 256
Laine, L., Curtis, S. P., Cryer, B., Kaur, A., & Cannon, C. P. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60234-7 · Cited by 251
Systematic reviews and meta-analyses of randomized trials: principles and pitfalls
da Costa, B. R., & Jüni, P. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu424 · Cited by 247
Self-citationOsteoarthritis: rational approach to treating the individual
Jüni, P., Reichenbach, S., & Dieppe, P. (2006) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2006.05.002 · Cited by 237
Self-citationZeng, C., Wei, J., Persson, M. S. M., Sarmanova, A., Doherty, M., Xie, D., Wang, Y., Li, X., Li, J., Long, H., et al. (2018) · British Journal of Sports Medicine · doi:10.1136/bjsports-2017-098043 · Cited by 223
Efficacy and safety of opioids for osteoarthritis: a meta-analysis of randomized controlled trials
Avouac, J., Gossec, L., & Dougados, M. (2007) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2007.02.006 · Cited by 167
Osteoarthritis – a case for personalized health care?
Karsdal, M. A., Christiansen, C., Ladel, C., Henriksen, K., Kraus, V. B., & Bay-Jensen, A. C. (2014) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2013.10.018 · Cited by 165
Cooper, N. J., Sutton, A. J., Lu, G., & Khunti, K. (2006) · Archives of Internal Medicine · doi:10.1001/archinte.166.12.1269 · Cited by 152
Self-citationManagement of Osteoarthritis in General Practice in Australia
Brand, C. A., Harrison, C. M., Tropea, J., Hinman, R. S., Britt, H. C., & Bennell, K. L. (2013) · Arthritis Care & Research · doi:10.1002/acr.22197 · Cited by 147
Rosemann, T. J., Wensing, M., Joest, K., Backenstraß, M., Mahler, C., & Szécsényi, J. (2006) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-7-48 · Cited by 123
Meta‐analysis of mixed treatment comparisons at multiple follow‐up times
Lu, G., Ades, A. E., Sutton, A. J., Cooper, N. J., Briggs, A. H., & Caldwell, D. M. (2007) · Statistics in Medicine · doi:10.1002/sim.2831 · Cited by 117
Self-citationLarochelle, M. R., Zhang, F., Ross-Degnan, D., & Wharam, J. F. (2015) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.3776 · Cited by 114
Safety of Paracetamol in Osteoarthritis: What Does the Literature Say?
Conaghan, P. G., Arden, N., Avouac, B., Migliore, A., & Rizzoli, R. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00658-9 · Cited by 101
da Costa, B. R., Saadat, P., Basciani, R., Agarwal, A., Johnston, B. C., & Jüni, P. (2020) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2020.10.004 · Cited by 99
Self-citationJeffery, M. M., Hooten, W. M., Henk, H. J., Bellolio, F., Hess, E. P., Meara, E. R., Ross, J. S., & Shah, N. D. (2018) · BMJ · doi:10.1136/bmj.k2833 · Cited by 94
Persson, M. S. M., Stocks, J., Walsh, D. A., Doherty, M., & Zhang, W. (2018) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2018.08.008 · Cited by 93
Johnston, B. C., Patrick, D. L., Thorlund, K., Busse, J. W., da Costa, B. R., Schünemann, H. J., & Guyatt, G. H. (2013) · Health and Quality of Life Outcomes · doi:10.1186/1477-7525-11-211 · Cited by 81
Myers, J. A., Wielage, R. C., Han, B., Price, K., Gahn, J. C., Paget, M.-A., & Happich, M. (2014) · BMC Musculoskeletal Disorders · doi:10.1186/1471-2474-15-76 · Cited by 57
Desai, R. J., Jin, Y., Franklin, P. D., Lee, Y., Bateman, B. T., Lii, J., Solomon, D. H., Katz, J. N., & Kim, S. C. (2019) · Arthritis & Rheumatology · doi:10.1002/art.40834 · Cited by 43
Adebajo, A. (2012) · BMC Family Practice · doi:10.1186/1471-2296-13-23 · Cited by 38
Gastrointestinal safety of etoricoxib in osteoarthritis and rheumatoid arthritis: A meta-analysis
Feng, X., Tian, M., Zhang, W., & Mei, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0190798 · Cited by 38
Factors Associated With Opioid Use in Presurgical Knee, Hip, and Spine Osteoarthritis Patients
Power, J. D., Perruccio, A. V., Gandhi, R., Veillette, C., Davey, J. R., Lewis, S. J., Syed, K., Mahomed, N. N., & Rampersaud, Y. R. (2019) · Arthritis Care & Research · doi:10.1002/acr.23831 · Cited by 36
Alsabbagh, M. W., Chang, F., Cooke, M. J., Elliott, S. J., & Chen, M. (2021) · Addiction · doi:10.1111/add.15571 · Cited by 30
Cao, Z., Zhou, J., Long, Z., Li, Y., Sun, J., Luo, Y., & Wang, W. (2020) · Aging · doi:10.18632/aging.202232 · Cited by 18
Cited by
Tang, S., Zhang, C., Oo, W. M., Fu, K., Risberg, M. A., Bierma-Zeinstra, S. M., Neogi, T., Atukorala, I., Malfait, A.-M., Ding, C., et al. (2025) · Nature Reviews Disease Primers · doi:10.1038/s41572-025-00594-6 · Cited by 476
Injectable and biodegradable piezoelectric hydrogel for osteoarthritis treatment
Vinikoor, T., Dzidotor, G. K., Le, T. T., Liu, Y., Kan, H.-M., Barui, S., Chorsi, M. T., Curry, E. J., Reinhardt, E., Wang, H., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-41594-y · Cited by 344
Kloppenburg, M., Namane, M., & Cicuttini, F. (2025) · The Lancet · doi:10.1016/s0140-6736(24)02322-5 · Cited by 280
Sohail, R., Mathew, M., Patel, K. K., Reddy, S. A., Haider, Z., Naria, M., Habib, A., Abdin, Z. U., Razzaq Chaudhry, W., & Akbar, A. (2023) · Cureus · doi:10.7759/cureus.37080 · Cited by 239
Feng, J., Li, Z., Tian, L., Mu, P., Hu, Y., Xiong, F., & Ma, X. (2022) · BMC Complementary Medicine and Therapies · doi:10.1186/s12906-022-03740-9 · Cited by 33
Metadata
- Authors
- da Costa, B. R., Pereira, T. V., Saadat, P., Rudnicki, M., Iskander, S. M., Bodmer, N. S., Bobos, P., Gao, L., Kiyomoto, H. D., Montezuma, T., Almeida, M. O., Cheng, P.-S., Hincapié, C. A., Hari, R., Sutton, A. J., Tugwell, P., Hawker, G. A., & Jüni, P.
- Venue
- BMJ
- Publisher
- BMJ
- Published
- 2021-10-12
- Volume
- 375
- Pages
- n2321
- ISSN
- 1756-1833 (ISSN-L)
- OpenAlex
- W3206683668
- Cited by
- 377
- References
- 59
- FWCI
- 35.45
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.